This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Simon Patrick Keiser in Biotechnology
Introduction
Simon Patrick Keiser, an inventive mind located in Aarau, Switzerland, is recognized for his contributions to the field of biotechnology. With a strong focus on immunotherapy, he has developed groundbreaking technologies that hold significant promise in the treatment of diseases. His sole patent stands as a testament to his innovative spirit and dedication to improving health outcomes through scientific advancements.
Latest Patents
Simon Patrick Keiser holds a notable patent entitled "Antibodies binding to HLA-A2/MAGE-A4." This invention pertains to antibodies that specifically bind to HLA-A2/MAGE-A4, including multispecific antibodies designed for T cell activation. The patent also encompasses polynucleotides that encode such antibodies, along with vectors and host cells that incorporate these polynucleotides. Furthermore, the patent outlines production methods for these antibodies and their potential therapeutic uses, highlighting their importance in medical treatment and disease management.
Career Highlights
Simon is currently associated with Hoffmann-La Roche Inc., a leading player in the pharmaceutical and biotechnology industry. His work there emphasizes his commitment to research and innovation, allowing him to collaborate with other experts to develop cutting-edge medical solutions.
Collaborations
In his professional journey, Simon collaborates closely with his coworker, Lydia Jasmin Hanisch. Their partnership enriches the research and development processes at Hoffmann-La Roche Inc., fostering an environment of creativity and teamwork which is essential for groundbreaking discoveries in biotechnology.
Conclusion
Simon Patrick Keiser exemplifies the spirit of innovation within the biotech field. With a unique patent focusing on innovative antibody technologies, he is making significant strides in the fight against diseases. His dedication to research and collaboration with esteemed professionals like Lydia Jasmin Hanisch further enhances his impact on the industry, positioning him as a noteworthy inventor in the realm of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile